Haematologica
(May 2020)
Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial
- Sandra Maria Dold,
- Mandy-Deborah Möller,
- Gabriele Ihorst,
- Christian Langer,
- Wolfram Pönisch,
- Lars-Olof Mügge,
- Stefan Knop,
- Johannes Jung,
- Christine Greil,
- Ralph Wäsch,
- Monika Engelhardt
Affiliations
- Sandra Maria Dold
- Dept. of Medicine I Hematology and Oncology, Medical Center - University of Freiburg, Germany;
- Mandy-Deborah Möller
- Dept. of Medicine I Hematology, Oncology, CCCF, Medical Center - University of Freiburg, Germany;
- Gabriele Ihorst
- Clinical Trials Unit, University of Freiburg Medical Center, Freiburg, Germany;
- Christian Langer
- Hematology, Oncology and Rheumatology, University of Ulm Medical Center, Ulm, Germany;
- Wolfram Pönisch
- Hematology and Oncology, University of Leipzig Medical Center, Leipzig, Germany;
- Lars-Olof Mügge
- University of Jena Medical Center and Heinrich-Braun-Klinikum Zwickau, Würzburg, Germany;
- Stefan Knop
- Hematology and Oncology, University of Würzburg Medical Center, Würzburg, Germany;
- Johannes Jung
- Medical Center - University of Freiburg and Comprehensive Cancer Center, Freiburg, Germany
- Christine Greil
- Medical Center - University of Freiburg and Comprehensive Cancer Center, Freiburg, Germany
- Ralph Wäsch
- Medical Center - University of Freiburg and Comprehensive Cancer Center, Freiburg, Germany
- Monika Engelhardt
- Medical Center - University of Freiburg and Comprehensive Cancer Center, Freiburg, Germany
- DOI
-
https://doi.org/10.3324/haematol.2020.254235
- Journal volume & issue
-
Vol. 106,
no. 3
WeChat QR code